GT Biopharma (GTBP) Return on Sales [ROS] (2010 - 2016)
GT Biopharma's Return on Sales [ROS] came in at -55085.00% for Q1 2016, down 29213.57 percentage points from -25871.43% a year earlier and down 22022.04 percentage points from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Return on Sales [ROS] (2010 - 2016) Analysis & Trends
For FY2015, GT Biopharma's Return on Sales [ROS] was -33062.96%, down 29135.09 percentage points from FY2014.
- Return on Sales [ROS] carries a five-year change of -10362.96 percentage points (FY2010 to FY2015).
- Going back by year, Return on Sales [ROS] was -3927.87% in FY2014, -1027.49% in FY2012 (+14080.21 pp) and -15107.69% in FY2011 (+7592.31 pp).
- The Q1 2016 figure represents the lowest quarterly Return on Sales [ROS] since Q2 2012.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q1 2013 (a gain of 39205.68 percentage points), and the weakest in Q2 2012 (a drop of 54900.00 percentage points).
- Business Quant data shows GTBP's Return on Sales [ROS] at -33062.96% (Q4 2015), -28374.07% (Q3 2015) and -7155.00% (Q2 2015) in the three quarters before Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | GT Biopharma | 8.58 Mn | 8.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | -55,085.00% |
| Dec 31, 2015 | -33,062.96% |
| Sep 30, 2015 | -28,374.07% |
| Jun 30, 2015 | -7,155.00% |
| Mar 31, 2015 | -25,871.43% |
| Mar 31, 2014 | -143.56% |
| Mar 31, 2013 | -394.32% |
| Dec 31, 2012 | -337.44% |
| Sep 30, 2012 | -1,125.00% |
| Jun 30, 2012 | -103,000.00% |
| Mar 31, 2012 | -39,600.00% |
| Dec 31, 2011 | -34,933.33% |
| Sep 30, 2011 | -27,050.00% |
| Jun 30, 2011 | -48,100.00% |
| Mar 31, 2011 | -9,290.00% |
| Dec 31, 2010 | -4,790.91% |
API Access
GT Biopharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();